Subscribe to RSS
DOI: 10.1055/s-0038-1648969
Interaction of Antistasin-Related Peptides with Factor Xa: Identification of a Core Inhibitory Sequence
Publication History
Received 01 February 1994
Accepted after resubmission 23 August 1994
Publication Date:
06 July 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199406/lookinside/thumbnails/10-1055-s-0038-1648969-1.jpg)
Summary
Antistasin, isolated from the Mexican leech, is a 119 amino acid protein which is a selective and potent inhibitor of coagulation Factor Xa. Previous studies indicated that an arginine residue located at position 34 of the inhibitor was cleaved by Factor Xa during the inhibition reaction. To evaluate this residue as the reactive site of antistasin, and to define shorter fragments of antistasin displaying Factor Xa-inhibitory activity, a series of peptides were synthesized corresponding to amino acids 27- 49 of the inhibitor. The most potent peptide synthesized was a disulfide-bridged, 19 amino acid peptide, ATS29-47, which inhibited Factor Xa with a Ki = 35 nM, and increased plasma clotting times by over 4-fold at a concentration of 33 uM. Reduction or sulfation of the cysteine residues in ATS29-47 reduced Factor Xa inhibitory activity by over 95%. Peptides as short as seven residues corresponding to position 33-39 of antistasin displayed Factor Xa inhibitory activity. The peptides did not inhibit thrombin or trypsin at concentrations 1000-fold higher than used in Factor Xa assays. The shortest peptide displaying anticoagulant activity in human plasma was the disulfide-bridged peptide, D-Arg-Cys-Arg-Val-His-Cys-Pro, which increased clotting times by 50% at micromolar concentrations. These results demonstrate that antistasin-related peptide sequences can serve as model structures for the development of novel, low molecular weight anticoagulants.
-
References
- 1 Tuszynski GP, Gasic TB, Gasic GJ. Isolation and characterization of anti-stasin, an inhibitor of metastasis and coagulation. J Biol Chem 1987; 262: 9718-9723
- 2 Nutt E, Gasic TB, Rodkey J, Gasic GJ, Jacobs JW, Freidman PA, Simpson E. The Amino Acid Sequence of Antistasin: A Potent Inhibitor of Factor Xa Reveals a Repeated Internal Structure. J Biol Chem 1988; 263: 10162-10167
- 3 Dunnwiddie C, Thomberry NA, Bull HG, Sardanna M, Freidman PA, Jacobs JW, Simpson E. Antistasin, a Leech-derived Inhibitor of Factor Xa: Kinetic Analysis of Enzyme Inhibition and Identification of the Reactive Site. J Biol Chem 1989; 264: 16694-16699
- 4 Dunwiddie CT, Vlasuk GP, Nutt EM. The Hydrolysis and Resynthesis of a Single Reactive Site Peptide Bond in Recombinant Antistasin by Coagulation Factor Xa. Arch Biochem Biophys 1992; 294: 647-653
- 5 Noguchi K, Matsuo K, Ohta N. Synthesis of Peptides Related to Immunoglobulin E (IgE) and the Examination of Their Pharmacological Activity. Chem Pharm Bull 1990; 38: 2463-2466
- 6 Okada Y, Ohta N, Yagyu M, Kyong-Son M, Onosoka S, Tanaka K. Synthesis of a Nonacosapeptide Corresponding to the N-Terminal Sequence 1-29 of Human Liver Metallothionein II and its Heavy Metal-Binding Properties. FEBS Let 1985; 183: 375-378
- 7 Ellman GL. Determination of Sulfhydryl Groups in Proteins By a Coloro-metric Assay. Arch Biochem Biophys 1959; 82: 70-79
- 8 Williams JW, Morrison JF. The kinetics of reversible tight-binding inhibition. Methods Enzymol 1979; 63: 437-467
- 9 O’Neill L, Tung J, Dunwiddie C, Alves K, Lenny A, Przysiecki C, Lehman D, Nutt E, Cuca G, Law S, Silberklang M, Ellis R, Mark G. Expression and Characterization of the N-Terminal Half of Antistasin, an AnticoagulantProtein Derived from the Leech Haementeria officinalis. Prot Express Purif 1991; 2: 37-42
- 10 Laskowski M, Kato I. Protease Inhibitors. Ann Rev Biochem 1980; 49: 593-626
- 11 Kettner C, Mersinger L, Knabb R. The Selective Inhibition of Thrombin by Peptides of Boroarginine. J Biol Chem 1990; 265: 18289-18297
- 12 Niall HD. Automated Sequence Analysis of Polypeptides. Methods Enzymol 1973; 27: 942-968